RecruitingPhase IIEN originalLung cancer

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The purpose of this study to find out whether giving BIO 300 in combination with thoracic radiation therapy is effective in preventing pneumonitis in people with non-small cell lung cancer (NSCLC) and interstitial lung disease (ILD).

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • •Wiek co najmniej 18 lat
  • •Rak płuca w stadium I lub II
  • •Potwierdzona diagnoza choroby śródmiąższowej płuc
  • •Zdolność do podpisania świadomej zgody na udział w badaniu
  • •Ogólny stan zdrowia pacjenta umożliwiający udział w badaniu
  • •Kobiety po menopauzie lub z negatywnym testem ciąży

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
September 16, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (7)

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

Basking Ridge, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities)

Middletown, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities)

Montvale, United States

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)

Commack, United States

Memorial Sloan Kettering Westchester (Limited Protocol Activities)

East White Plains, United States

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

New York, United States

Memorial Sloan Kettering Nassau (Limited Protocol Activities)

Uniondale, United States

Trial contact

Narek Shaverdian, MD

Jamie Chaft, MD

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/17/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.